Aveo Pharmaceuticals (AVEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2008 | |
| Cash Flows From Operating Activities | |
| Net Income | -32,470 |
| Depreciation Amortization | 820 |
| Other Working Capital | -6,680 |
| Other Operating Activity | 3,030 |
| Operating Cash Flow | $-35,300 |
| Cash Flows From Investing Activities | |
| PPE Investments | -1,350 |
| Other Investing Activity | 29,500 |
| Investing Cash Flow | $28,150 |
| Cash Flows From Financing Activities | |
| Other Financing Activity | 6,880 |
| Financing Cash Flow | $6,880 |
| Beginning Cash Position | 21,080 |
| End Cash Position | 20,810 |
| Net Cash Flow | $-260 |
| Free Cash Flow | |
| Operating Cash Flow | -35,300 |
| Free Cash Flow | -35,300 |